Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
Total Liabilities
Interpace Biosciences Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Interpace Biosciences Inc
OTC:IDXG
|
Total Liabilities
$26.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
DaVita Inc
NYSE:DVA
|
Total Liabilities
$16.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Liabilities
$7.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Total Liabilities
$175.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
18%
|
|
Cigna Corp
NYSE:CI
|
Total Liabilities
$111.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
10%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Liabilities
$8.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
7%
|
See Also
What is Interpace Biosciences Inc's Total Liabilities?
Total Liabilities
26.7m
USD
Based on the financial report for Mar 31, 2024, Interpace Biosciences Inc's Total Liabilities amounts to 26.7m USD.
What is Interpace Biosciences Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
-2%
Over the last year, the Total Liabilities growth was -16%. The average annual Total Liabilities growth rates for Interpace Biosciences Inc have been -4% over the past three years , 8% over the past five years , and -2% over the past ten years .